Labs / Assays & in vitro testing
Samsung Biologics
Incheon, South Korea · samsungbiologics.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Samsung Biologics is a biopharma CDMO in Incheon, Republic of Korea, with a Rockville campus in the United States. It provides end-to-end services from research and development through commercial manufacturing, aseptic fill-finish, and analytical testing for biopharma companies.
Their website has a general contact form; we send your quote request through it.
What they offer
Organoid Services
Provides patient-derived organoid models and screening services to support precision drug discovery and translational research.
Late Discovery
Supports lead optimization and developability assessment using proprietary platforms for early biologics discovery.
Cell Line Development
Develops high-titer CHO cell lines to support faster IND/IMPD submission.
Process Development
Develops bioprocesses to support scale-up and clinical readiness.
Analytical Development
Develops analytical methods to support characterization and development workflows.
Non-GMP / CGMP Manufacturing
Provides non-GMP and CGMP manufacturing for drug substance and drug product across clinical development stages.
Drug Substance Manufacturing
Manufactures drug substance at clinical and commercial scale.
Drug Product Manufacturing
Manufactures drug product for clinical and commercial supply.
Aseptic Fill-Finish
Provides aseptic filling, lyophilization, automated inspection, and packaging support.
Analytical Testing Services
Provides laboratory testing services across biopharmaceutical product stages.
Bioconjugation
Provides advanced modalities services for bioconjugation development and manufacturing.
mRNA Services
Provides process development and manufacturing services for pDNA, IVT, and LNP-related mRNA work.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Peptide, mRNA, LNP / formulation
- Species and models
- CHO cell lines, CHOZN cell lines, MRC-5, Vero, CHO-K1, A9, NIH3T3, patient-derived tumor organoids, 3D tumor models
- Assays and studies
- precision drug screening, developability assessment, analytical testing, mycoplasma test, in vitro virus test, MVM qPCR test, microbiology test, contract quality control testing, endotoxin test, sterility test, bioburden test
- Instruments and platforms
- Octet® HTX, AKTA, UF/DF equipment
- Scale and capacity
- 845 kL total capacity, 50 L and 200 L single-use bioreactor manufacturing, 1 kL manufacturing support, 5–15 kL large-scale drug substance, ≤2 kL small-scale drug substance, 2R-50R aseptic vial filling, Bio Campus II completion scheduled for 2032
- Therapeutic areas
- oncology
- Turnaround
- 1 month for DEVELOPICK® · 7 months from cell line development to IND filing for mAb · 9.5 months from gene to IND filing for BsAb
- What to send
- 80 mg minimum material for DEVELOPICK® · patient tumor tissue for organoid generation · parental antibody sequences for S-DUAL®
- Minimums and prices
- Competitive pricing for S-DUAL® (no amount stated)
- Type
- CRDMO
- Sites
- Incheon, Republic of Korea · Rockville, United States
- Quality
- CGMP compliant (facilities and manufacturing operations) · 510+ regulatory approvals · 99% batch success rate
- Serves
- global
Public records
Similar labs. Esco Aster, Hope Medicine (HopeMed), enGenes, Evotec
Found in a contract services directory. Listing built from samsungbiologics.com. Work here? Claim this listing.